Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures - Operating Segments (Details)

v3.20.2
Segment Disclosures - Operating Segments (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
segment
Sep. 30, 2019
USD ($)
Segment Reporting Information [Line Items]        
Number of reportable segments | segment     2  
Revenue $ 2,897 $ 3,319 $ 6,628 $ 10,197
Cost of revenue 1,084 1,569 2,919 5,288
Gross profit 1,813 1,750 3,709 4,909
EksoHealth        
Segment Reporting Information [Line Items]        
Revenue 2,739 2,999 6,015 8,661
Cost of revenue 989 1,297 2,466 3,932
Gross profit 1,750 1,702 3,549 4,729
EksoWorks        
Segment Reporting Information [Line Items]        
Revenue 158 320 613 1,536
Cost of revenue 95 272 453 1,356
Gross profit $ 63 $ 48 $ 160 $ 180